As of 11:02 on November 13, 2024, the SSE STAR Market 50 Component Index (000688) fell by 0.20%. In terms of constituent stocks, it was mixed, led by Kingsoft Office (688111) with a rise of 5.81%, Tuojing Technology (688072) with a rise of 5.48%, and Cambrian (688256) with a rise of 4.73%; Junshi Biosciences (688180) led the decline, followed by Yirui Technology (688301) and Fudan Microelectronics (688385). The intraday volume turnover of the leading Kechuang 50 ETF (588060) has reached 1.089 billion yuan, with a turnover rate of 18.77%; Buying is active, or there are funds to lay out the dip!

In terms of scale, the latest scale of the leading 50 ETF reached 5.818 billion yuan. In terms of share, the share of the leading 50 ETF has increased by 2.494 billion since the beginning of this year, achieving significant growth.

The data shows that leveraged funds continue to be deployed. The latest financing purchase amount of the leading 50 ETF reached 45.5594 million yuan, and the latest financing balance reached 295 million yuan.

The STAR 50 ETF closely tracks the SSE STAR Market 50 Component Index, which is composed of 50 securities with large market capitalization and good liquidity in the Shanghai Stock Exchange's STAR Market, reflecting the overall performance of the most representative group of science and technology enterprises in the market.

According to the data, as of October 31, 2024, the top 10 weighted stocks of the SSE Science and Technology Innovation Board 50 Component Index (000688) are SMIC (688981), Haiguang Information (688041), Cambrian (688256), China Micro Corporation (688012), Montage Technology (688008), Kingsoft Office (688111), Transsion Holdings (688036), United Imaging Healthcare (688271), JinkoSolar (688223), Shanghai Silicon Industry (688126), the top ten weighted stocks accounted for 56.22%.

In terms of news, the deputy general manager of the Shanghai Stock Exchange recently said that the investment value of companies on the Science and Technology Innovation Board is continuing to increase. Focusing on four aspects, first, the innovation vitality continues to burst out. The average R&D investment intensity of the STAR Market remained above 10%, ranking first among all sectors of the A-share market. Second, the operating performance grew steadily. Since its opening, the compound growth rate of operating income and net profit attributable to the parent company of the Science and Technology Innovation Board has reached 23% and 24%; Third, the ability to return continues to improve. Up to now, 9 percent of the company has implemented cash dividends, with a cumulative amount of more than 140 billion yuan, and more than 7 percent of the company has implemented dividends in more than two years. Fourth, the investment ecology is gradually optimized. The STAR Market has formed 25 index systems covering "broad-based + theme + strategy" to continue to guide incremental capital and long-term capital inflows.

Bank of China Securities said that for A-shares, last Friday's fiscal increase stimulus boots landed, which played an effective role in repairing and strengthening long-term confidence in the market. At present, the data signals for the repair of domestic demand are still differentiated. It remains to be seen how the policy of stabilizing growth will be released and the expected recovery of domestic demand remains to be observed. Next week, the domestic economic and financial data for October will be released, and the market may face a window period for data verification. In the short term, the market will continue to drive the volatile upward market driven by the denominator in the context of monetary easing + policy expectations gradually released, which is good for technology growth stocks.

STAR 50 ETF Leader (588060), OTC Connect (Class A: 013810; Category C: 013811; GF STAR 50 ETF Initiation Connection F: 021768).